| Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies K Gudala, D Bansal, F Schifano, A Bhansali Journal of diabetes investigation 4 (6), 640-650, 2013 | 731 | 2013 |
| Mephedrone, new kid for the chop? AR Winstock, LR Mitcheson, P Deluca, Z Davey, O Corazza, F Schifano Addiction 106 (1), 154-161, 2011 | 437 | 2011 |
| Mephedrone (4-methylmethcathinone;‘meow meow’): chemical, pharmacological and clinical issues F Schifano, A Albanese, S Fergus, JL Stair, P Deluca, O Corazza, Z Davey, ... Psychopharmacology 214, 593-602, 2011 | 369 | 2011 |
| Novel psychoactive substances of interest for psychiatry F Schifano, L Orsolini, G Duccio Papanti, JM Corkery World Psychiatry 14 (1), 15-26, 2015 | 334 | 2015 |
| MDMA (ecstasy') consumption in the context of polydrug abuse: a report on 150 patients F Schifano, L Di Furia, G Forza, N Minicuci, R Bricolo Drug and alcohol dependence 52 (1), 85-90, 1998 | 317 | 1998 |
| Misuse and abuse of pregabalin and gabapentin: cause for concern? F Schifano CNS drugs 28 (6), 491-496, 2014 | 314 | 2014 |
| Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi‐site prospective cohort study M Davoli, AM Bargagli, CA Perucci, P Schifano, V Belleudi, M Hickman, ... Addiction 102 (12), 1954-1959, 2007 | 283 | 2007 |
| “Legal highs” on the net—Evaluation of UK-based Websites, products and product information MM Schmidt, A Sharma, F Schifano, C Feinmann Forensic science international 206 (1-3), 92-97, 2011 | 277 | 2011 |
| When “chems” meet sex: a rising phenomenon called “chemsex” R Giorgetti, A Tagliabracci, F Schifano, S Zaami, E Marinelli, FP Busardò Current neuropharmacology 15 (5), 762-770, 2017 | 275 | 2017 |
| “Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report D Papanti, F Schifano, G Botteon, F Bertossi, J Mannix, D Vidoni, ... Human Psychopharmacology: Clinical and Experimental 28 (4), 379-389, 2013 | 270 | 2013 |
| Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project P Deluca, Z Davey, O Corazza, L Di Furia, M Farre, LH Flesland, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 39 (2), 221-226, 2012 | 257 | 2012 |
| Statin use and risk of prostate cancer: a meta-analysis of observational studies D Bansal, K Undela, S D'Cruz, F Schifano Public Library of Science 7 (10), e46691, 2012 | 237 | 2012 |
| A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities F Schifano Psychopharmacology 173, 242-248, 2004 | 237 | 2004 |
| Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data F Schifano, S D’Offizi, M Piccione, O Corazza, P Deluca, Z Davey, ... Psychotherapy and psychosomatics 80 (2), 118-122, 2011 | 232 | 2011 |
| New trends of substance abuse during COVID-19 pandemic: an international perspective S Zaami, E Marinelli, MR Varì Frontiers in Psychiatry 11, 560756, 2020 | 220 | 2020 |
| Cannabidiol (CBD) use in psychiatric disorders: A systematic review S Bonaccorso, A Ricciardi, C Zangani, S Chiappini, F Schifano Neurotoxicology 74, 282-298, 2019 | 214 | 2019 |
| A decade of gabapentinoid misuse: an analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ database S Chiappini, F Schifano CNS drugs 30, 647-654, 2016 | 202 | 2016 |
| COVID-19: the hidden impact on mental health and drug addiction S Chiappini, A Guirguis, A John, JM Corkery, F Schifano Frontiers in psychiatry 11, 767, 2020 | 196 | 2020 |
| The effects of methadone and its role in fatalities JM Corkery, F Schifano, AH Ghodse, A Oyefeso Human Psychopharmacology: Clinical and Experimental 19 (8), 565-576, 2004 | 186 | 2004 |
| An insight into Z-drug abuse and dependence: an examination of reports to the European medicines agency database of suspected adverse drug reactions F Schifano, S Chiappini, JM Corkery, A Guirguis International Journal of Neuropsychopharmacology 22 (4), 270-277, 2019 | 185 | 2019 |
